BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37709251)

  • 1. Chronic inflammation promotes cancer progression as a second hit.
    Burocziova M; Grusanovic S; Vanickova K; Kosanovic S; Alberich-Jorda M
    Exp Hematol; 2023 Dec; 128():30-37. PubMed ID: 37709251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Transformation Involving
    Olofsen PA; Fatrai S; van Strien PMH; Obenauer JC; de Looper HWJ; Hoogenboezem RM; Erpelinck-Verschueren CAJ; Vermeulen MPWM; Roovers O; Haferlach T; Jansen JH; Ghazvini M; Bindels EMJ; Schneider RK; de Pater EM; Touw IP
    Cell Rep Med; 2020 Aug; 1(5):100074. PubMed ID: 33205068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis in patients with hematologic malignancies].
    Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
    Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
    Beekman R; Valkhof MG; Sanders MA; van Strien PM; Haanstra JR; Broeders L; Geertsma-Kleinekoort WM; Veerman AJ; Valk PJ; Verhaak RG; Löwenberg B; Touw IP
    Blood; 2012 May; 119(22):5071-7. PubMed ID: 22371884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
    Jafek JL; Shakya A; Tai PY; Ibarra A; Kim H; Maddox J; Chumley J; Spangrude GJ; Miles RR; Kelley TW; Tantin D
    Exp Hematol; 2019 Aug; 76():38-48.e2. PubMed ID: 31295506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathobiology of acute myeloid leukemia].
    Christ O; Feuring-Buske M; Hiddemann W; Buske C
    Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers.
    Gasparetto M; Smith CA
    Chem Biol Interact; 2017 Oct; 276():46-51. PubMed ID: 28645468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation.
    Reikvam H; Hatfield KJ; Fredly H; Nepstad I; Mosevoll KA; Bruserud Ø
    Eur Cytokine Netw; 2012; 23(4):140-53. PubMed ID: 23328436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
    Zhang J; Kong G; Rajagopalan A; Lu L; Song J; Hussaini M; Zhang X; Ranheim EA; Liu Y; Wang J; Gao X; Chang YI; Johnson KD; Zhou Y; Yang D; Bhatnagar B; Lucas DM; Bresnick EH; Zhong X; Padron E; Zhang J
    Blood; 2017 Jan; 129(3):358-370. PubMed ID: 27815262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of myeloid malignancies.
    Kitamura T; Inoue D; Okochi-Watanabe N; Kato N; Komeno Y; Lu Y; Enomoto Y; Doki N; Uchida T; Kagiyama Y; Togami K; Kawabata KC; Nagase R; Horikawa S; Hayashi Y; Saika M; Fukuyama T; Izawa K; Oki T; Nakahara F; Kitaura J
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):389-404. PubMed ID: 25504228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of the Role of Runt-Related Transcription Factor 1 (RUNX1) in the Pathogenesis of Hematological Malignancies in Patients With Inherited Bone Marrow Failure Syndromes.
    Illango J; Sreekantan Nair A; Gor R; Wijeratne Fernando R; Malik M; Siddiqui NA; Hamid P
    Cureus; 2022 May; 14(5):e25372. PubMed ID: 35765406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in understanding the biology and genetics of acute myelocytic leukemia.
    McKenzie SB
    Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
    Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
    Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML.
    Botezatu L; Michel LC; Helness A; Vadnais C; Makishima H; Hönes JM; Robert F; Vassen L; Thivakaran A; Al-Matary Y; Lams RF; Schütte J; Giebel B; Görgens A; Heuser M; Medyouf H; Maciejewski J; Dührsen U; Möröy T; Khandanpour C
    Exp Hematol; 2016 Aug; 44(8):713-726.e14. PubMed ID: 27216773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.